Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-βe signaling

被引:8
作者
Imoto, S
Sugiyama, K
Sekine, Y
Matsuda, T
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 6060812, Japan
[2] Nippon Boehringer Ingelheim Co Ltd, Kawanishi Pharma Res Inst, Kawanishi, Hyogo 6660193, Japan
关键词
TGF-beta; Smad; mad homology 2 domain; lysine; transcription;
D O I
10.1016/j.febslet.2005.04.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sma and MAD-related protein 3 (Smad3) plays a key role in the intracellular signaling of the transforming growth factor-beta (TGF-beta) family of growth factors, which exhibits a diverse set of cellular responses, including cell proliferation and differentiation. Smad3 has the N-terminal Mad homology (MH) 1 and the C-terminal MH2 domains. MH2 domain is essential for the TGF-beta-induced transcriptional activation, because the MH2 domain of Smad3 is involved in the interactions with several transcriptional cofactors as well as the type I TGF-beta receptor (T beta R-I). In this study, we examined the roles for four lysine residues (Lys-333, Lys-341, Lvs-378, and Lys-409) in the Smad3 MH2 domain. Mutation of the lysine (K)-378 to arginine (R) (K378R) abolished the interaction with T beta R-I, phosphorylation, transcriptional activation by an active T beta R-I. The K341R mutant also failed to stimulate TGF-beta-induced transcription by resting in the cytoplasm. However, the K409R mutant showed a higher transcriptional activity by stronger interactions with coactivators, such as p300/CBP. Furthermore, both the K341R and K378R mutants act as dominant-negative inhibitors in the TGF-beta-induced target genes of endogenous TGF-beta signal. Thus, the lysine residues of Smad3 MH2 domain play important roles in the transcriptional regulation of TGF-beta signals through T beta R-I. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2853 / 2862
页数:10
相关论文
共 53 条
[1]   c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads [J].
Akiyoshi, S ;
Inoue, H ;
Hanai, J ;
Kusanagi, K ;
Nemoto, N ;
Miyazono, K ;
Kawabata, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) :35269-35277
[2]   Smads as transcriptional co-modulators [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :235-243
[3]   Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[4]  
CARCAMO J, 1995, MOL CELL BIOL, V15, P1573
[5]   Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7 [J].
Clement, JH ;
Marr, N ;
Meissner, A ;
Schwalbe, M ;
Sebald, W ;
Kliche, KO ;
Höffken, K ;
Wölfl, S .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (05) :271-279
[6]   Smads:: Transcriptional activators of TGF-β responses [J].
Derynck, R ;
Zhang, Y ;
Feng, XH .
CELL, 1998, 95 (06) :737-740
[7]   Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation [J].
Ebisawa, T ;
Fukuchi, M ;
Murakami, G ;
Chiba, T ;
Tanaka, K ;
Imamura, T ;
Miyazono, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12477-12480
[8]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[9]   The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation [J].
Feng, XH ;
Zhang, Y ;
Wu, RY ;
Derynck, R .
GENES & DEVELOPMENT, 1998, 12 (14) :2153-2163
[10]   SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? [J].
Gill, G .
GENES & DEVELOPMENT, 2004, 18 (17) :2046-2059